Neuroscience and Artificial Intelligence Webinar
March 4, 2021
Fireside Chat:
Bill Martin, Global Therapeutic Area Head, Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson
Angela Wilkins, Executive Director, Ken Kennedy Institute at Rice University (moderator)
Panel #1: Novel Therapeutic Approaches: Using AI to understand and address CNS indications
This conversation will explore how AI can be leveraged to elucidate underlying mechanisms and enable more informative diagnostics for CNS indications.
Naheed Kurji, CEO, Cyclica (moderator)
Charles Fisher, CEO, Unlearn AI
Alex Zhavoronkov, Ph.D., CEO, InSilico
Lynn Durham, CEO, Stalica
Panel #2: AI-enabled medical devices & digital solutions for behavioral health
This session will focus on understanding innovation in tools to track and manage behavioral health in the absence of clinical interventions.
Luba Greenwood, Managing Partner at Dana-Farber Cancer Institute Venture Fund (moderator)
Oliver Gassner, Digital Health Leader, Neuroscience, Roche
Michael Langer, Senior Manager and Head of Search, Evaluation & In-Licensing, Pear Therapeutics
Marci Campbell, VP of Products, Clarigent Health